Management of epilepsy in adolescents and adults

Lancet

Volumn 356, Issue 9226, 2000, Pages 323-329

  Brodie, Martin J ^a   French, Jacqueline A ^b  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

DISEASE CLASSIFICATION; EPILEPSY; HUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SYNDROME DELINEATION;

EID: 0034702511     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02515-0     Document Type: Review

References (50)

1. Brodie M.J., Shorvon S.D., Canger R.et al. Commission on European Affairs. appropriate standards of epilepsy care across Europe Epilepsia. 38:1997;1245-1250.
2. Brodie M.J., Dichter M.A. Antiepileptic drugs. N Engl J Med. 334:1996;168-175.
3. Dichter M.A., Brodie M.J. New antiepileptic drugs. N Engl J Med. 334:1996;1583-1590.
4. Engel J. Jr. Surgery for seizures. N Engl J Med. 334:1996;647-652.
5. Leestma J.E., Annegers J.F., Brodie M.J.et al. Sudden unexplained death in epilepsy. observations from a large clinical development programme Epilepsia. 38:1997;47-55.
6. Delanty N., Vaughan C.J., French J.A. Medical causes of seizures. Lancet. 352:1998;383-390.
7. French J.A. Pseudoseizures in the era of video-electroencephalogram monitoring. Curr Opin Neurol. 8:1995;117-120.
8. Duncan J.S. Imaging and epilepsy. Brain. 120:1997;339-377.
9. Commission on Classification and Terminology of the ILAE: proposal for revised clinical classification of epileptic seizures. Epilepsia. 22:1981;489-501.
10. Commission on Classification and Terminology of the ILAE: proposal for revised clinical classification of epilepsy and epileptic syndromes. Epilepsia. 30:1989;389-399.
11. Ronen G.M., Rosales T.O., Connolly M.et al. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology. 43:1993;1355-1360.
12. Singh N.A., Charlier C., Stauffer D.et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet. 18:1998;25-29.
13. Scheffer I.E., Berkovic S.F. Generalised epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 120:1997;479-490.
14. Wallace R.H., Wang D.W., Sing R.et al. Febrile seizures and generalised epilepsy associated with a mutation in the Na+ channel β1 submit gene SCNIB. Nat Genet. 19:1998;366-370.
15. Steinlein O.K., Mulley J.C., Propping P.et al. A mis-sense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet. 11:1995;201-203.
16. Scheffer I.E., Bhatia K.P., Lopes-Cenes I.et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain. 118:1995;61-73.
17. Mattson R.H., Cramer J.A., Collins J.F.et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary tonic-clonic seizures. N Engl J Med. 313:1985;145-151.
18. Mattson R.H., Cramer J.A., Collins J.F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic-clonic seizures in adults. N Engl J Med. 327:1992;765-771.
19. Perucca E., Gram L., Avenzini G., Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia. 39:1998;5-17.
20. French J.A. The long-term therapeutic management of epilepsy. Ann Int Med. 120:1994;411-422.
21. Cramer J.A., Fisher R., Ben-Menachem E., French J.A., Mattson R.H. New antiepileptic drugs. comparison of key clinical trials Epilepsia. 40:1999;590-620.
22. Marson A.G., Kadir Z.A., Hutton J.L., Chadwick D.W. The new antiepileptic drugs. a systematic review of their efficacy and tolerability Epilepsia. 38:1997;859-880.
23. Brodie M.J. Monostars: an aid to choosing an antiepileptic drug as monotherapy. Epilepsia. 40(suppl 6):1999;17-22.
24. French J.A., Mosier M., Walker A., Sommerville K., Sussman A. A double-blind placebo-controlled study of vigabatrin 3 g/day in patients with uncontrolled complex partial seizures. Neurology. 46:1996;54-61.
25. Eke T., Talbot J.F., Lawden M.C. Severe persistent visual field constriction associated with vigabatrin. BMJ. 314:1997;180-181.
26. Pellock J.M., Brodie M.J. Felbamate. an update Epilepsia. 38:1997;1261-1264.
27. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med. 342:2000;314-319.
28. Zahn C.A., Morrell M.J., Collins S.D., Labiner D.M., Yerby M.S. Management issues for women with epilepsy. a review of the literature Neurology. 51:1998;949-956.
29. Isojarvi J.I.T., Laatikainen T.J., Knip M., Pakarinen A.J., Juntunen K.T.S., Myllyla V.V. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol. 39:1996;579-584.
30. Crawford P., Appleton R., Betts T.et al. Best practice guidelines for the management of women with epilepsy. Seizure. 8:1999;201-217.
31. Stephen L.J., McLellan A.R., Harrison J.H.et al. Bone density and antiepileptic drugs. a case-controlled study Seizure. 8:1999;339-342.
32. Feely M., Gibson J. Intermittent clobazam for catamenial epilepsy. tolerance avoided J Neurol Neurosurg Psychiatry. 27:1984;1279-1282.
33. Yerby M.S. Contraception, pregnancy and lactation in women with epilepsy. Brodie M.J., Treiman D.M. Modern management of epilepsy - Baillière's Clinical Neurology. 1996;887-908 Baillière Tindall, London.
34. Koch S., Titze K., Zimmerman R.S., Schoder M., Lehmkuhl U., Rauh H. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia. 49:1999;1237-1243.
35. Stephen L.J., Brodie M.J. Epilepsy in elderly people. Lancet. 355:2000;1441-1446.
36. Brodie M.J., Overstall P.W., Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 37:1999;81-87.
37. Hannah J.A., Brodie M.J. Epilepsy and learning disabilities - a challenge for the next millenium. Seizure. 7:1998;3-13.
38. Scheepers B., Clough P., Pickles C. The misdiagnosis of epilepsy. findings of a population study Seizure. 7:1998;403-406.
39. Smith D., Defalla B.A., Chadwick D.W. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. Q J Med. 92:1999;15-23.
40. French J.A., Sirven J. Pseudoepileptic and psychogenic seizures. Johnson R.T., Griffin J.W. Current therapy in neurological disease. 1997;61-64 Mosby, London.
41. Brodie M.J., Yuen A.W.C. Lamotrigine substitution study: evidence for synergism with sodium valproate? Epilepsy Res. 26:1997;423-432.
42. Brodie M.J., Mumford J.P. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. Epilepsy Res. 34:1999;199-205.
43. Stephen L.J., Sills G.J., Brodie M.J. Lamotrigine and topiramate may be a useful combination. Lancet. 351:1998;958-959.
44. Ramsay R.E., De Toledo J. Acetazolamide. Engel J., Pedley T.A. Epilepsy: a comprehensive textbook. 1997;1455-1461 Lippincott-Raven, Philadelphia, USA.
45. Chadwick D. A practical guide to discontinuing antiepileptic drugs. CNS Drugs. 2:1994;423-428.
46. Schachter S.C., Saper C.B. Vagus nerve stimulation. Epilepsia. 39:1998;677-686.
47. Labar D., Murphy J., Tecoma E. Vagus nerve stimulation for medication-resistant generalised epilepsy. Neurology. 52:1999;1510-1512.
48. Radhakrishnan K., So E.L., Silbert P.L.et al. Predictors of outcome of anterior temporal lobectomy for intractable epilepsy. a multivariate study Neurology. 51:1998;465-471.
49. Vickery B.G., Hays R.D., Rausch R., Sutherling W.W., Engel J., Brook R.H. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia. 35:1994;597-607.
50. Picard F., Bertrand S., Steinlein O.K., Bertrand D. Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine. Epilepsia. 40:1999;1198-1209.